The Multistate Operator M&A Wave: Consolidation Signals Growth
By Sheeba M. | April 27, 2026 The Multistate Operator M&A Wave: Consolidation Signals Growth TL;DR: Cannabis MSO consolidation is accelerating. In Q1 2026, 11 major acquisitions were announced totaling $3.2B. This is typically a leading indicator of sector confidence—and suggests profitability is near. When multistate operators (MSOs) start consolidating aggressively, it usually means one […]
Cannabis Credit Crisis: Banks Still Avoiding the Industry
By Sheeba M. | April 27, 2026 Cannabis Credit Crisis: Banks Still Avoiding the Industry TL;DR: Despite federal rescheduling, major banks remain hesitant to finance cannabis operators. This creates a $12B funding gap that alternative lenders are exploiting—and it’s reshaping cannabis valuations across the sector. The cannabis industry has been waiting for federal policy to […]
Cannabis MSO Earnings Wave: Margin Pressure and Strategic Pivots Dominate Q1 Results
By Sheeba M. | April 26, 2026 Cannabis MSO Earnings Wave: Margin Pressure and Strategic Pivots Dominate Q1 Results TL;DR: Multi-state operators report Q1 earnings showing 8-12% margin compression as wholesale pricing pressures intensify. Green Thumb Industries, Curaleaf, and Trulieve all signal cost optimization as priority. Expect consolidation acceleration. The Margin Squeeze Hits Harder Than […]
The Cannabis Cash Flow Story Nobody’s Talking About: Why EBITDA Is the New EPS
By Sheeba M. | April 26, 2026 The Cannabis Cash Flow Story Nobody’s Talking About: Why EBITDA Is the New EPS TL;DR: Section 280E is still killing net income for cannabis operators, but smart investors are watching EBITDA and free cash flow instead. A 20%+ EBITDA margin operator can return cash to shareholders and fund […]
Cresco Labs Earnings Beat Sparks Rally as Margin Expansion Accelerates
By Sheeba M. | April 26, 2026 Cresco Labs Earnings Beat Sparks Rally as Margin Expansion Accelerates TL;DR: Cresco Labs posted Q1 2026 revenue of $412M, beating analyst expectations while EBITDA margins hit 22%—a key indicator that MSO consolidation and vertical integration are finally paying operational dividends. Wall Street is watching to see if this […]
Hemp’s Regulatory Time Bomb: November 2026 Changes Set to Reshape the Market
By Sheeba M. | April 26, 2026 Hemp’s Regulatory Time Bomb: November 2026 Changes Set to Reshape the Market TL;DR: New hemp-derived THC thresholds take effect November 2026, effectively recriminalizing much of the infused hemp market. Operators with compliant SKU portfolios will gain market share; over-leveraged hemp companies face existential risk. While headlines focus on […]
Medical Cannabis Rescheduling: The DEA’s Historic Move and What Investors Should Know
By Sheeba M. | April 26, 2026 Medical Cannabis Rescheduling: The DEA’s Historic Move and What Investors Should Know TL;DR: The DEA officially moved medical cannabis from Schedule I to Schedule III, unlocking banking access and reducing regulatory friction for state-licensed operators. Markets are repricing risk—but profitability remains the real story. In a historic reversal, […]
Federal Rescheduling Progress: De-Risking Cannabis Investments
By Sheeba M. | April 25, 2026 Federal Rescheduling Progress: De-Risking Cannabis Investments TL;DR: Recent federal movements toward cannabis rescheduling are reducing regulatory risk for institutional investors. Multi-state operators like Curaleaf and GTI stand to benefit most from banking access and capital market improvements. Cannabis rescheduling efforts at the federal level are accelerating. If cannabis […]
Cannabis Supply Chain Consolidation: What Investors Need to Know
By Sheeba M. | April 25, 2026 Cannabis Supply Chain Consolidation: What Investors Need to Know TL;DR: Consolidation in cannabis supply chains is creating winners among mid-cap operators. Companies like Curaleaf are leveraging scale to improve margins while smaller operators face pressure. The cannabis industry is entering a critical consolidation phase. Unlike the early gold-rush […]
SAFE Banking Act Momentum Builds: What It Means for Cannabis Investors
By Sheeba M. | April 25, 2026 SAFE Banking Act Momentum Builds: What It Means for Cannabis Investors TL;DR: Congressional support for SAFE Banking Act reaches bipartisan consensus; passage expected within 18 months could unlock $6B+ in institutional capital and trigger MSO valuation re-rating. The cannabis industry’s most significant near-term catalyst may finally be within […]